Northwire Canada EditionSunday, October 18, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
M&A / Property

Contagious still working on IMBiotechnologies RTO

By The Northwire Desk — AI Analysis Mar 12, 2026 · 11:33 CNS Contagious Gaming Inc
CNS · Price

Executive Summary

  • Contagious Gaming Inc. provides an update on its proposed reverse‑takeover transaction with IMBiotechnologies Ltd., originally announced on July 17, 2024.
  • Both parties remain in negotiations, conducting due‑diligence and working with advisers to determine the optimal legal structure; a definitive agreement has not yet been executed.
  • Trading of Contagious Gaming’s common shares remains halted on the TSX Venture Exchange pending completion of the transaction and related regulatory approvals.

Key Details

  • The parties entered into a non‑binding Letter of Intent for a reverse takeover; no definitive agreement is in place.
  • Ongoing activities include:
  • Negotiation and execution of a definitive agreement.
  • Completion of satisfactory due diligence by both Contagious Gaming and IMBiotechnologies.
  • Evaluation of a concurrent financing by IMBiotechnologies, with proceeds intended for commercialization activities and general corporate purposes.
  • Transaction is subject to customary closing conditions:
  • Execution of definitive agreement.
  • Satisfactory due‑diligence outcomes.
  • Completion of any required financing.
  • Receipt of all necessary shareholder and regulatory approvals.
  • Satisfaction of other standard closing conditions.
  • Trading Halt: Shares remain halted on the TSX Venture Exchange in accordance with exchange policies; trading will resume only after the exchange determines that conditions are met.
  • The company commits to provide further updates as material developments occur.

Notable Quotes

(No direct quotes were included in the release.)

Read the original news release →